PROCEDES POUR TRAITER LE DEREGLEMENT DU FACTEUR NUCLEAIRE D'AMPLIFICATEUR A CHAINE LEGERE KAPPA DE LYMPHOCYTE B ACTIVE (NF-.KAPPA.B) DANS UN HOTE DONT L'ETAT LE NECESSITE EN UTILISANT DES COMPOSITIONS DE MEMBRANE COQUILLIERE
The present invention relates to the use of eggshell membrane compositions to activate levels of nuclear factor kappa-light-chain-enhancer of activated B cells ("NF-??") in the gut of a host in need thereof and methods of treating conditions related to NF-KB dysregulation. The herein invention provides a method for activating NF-?? in the gut of a host in need thereof. The method comprises orally administering an effective amount of a composition consisting essentially of eggshell membrane, and/or eggshell membrane isolates and/or eggshell membrane hydrolysates for activation of NF-?? to the host.
